CONFERENCE
PRESENTATIONS
CONFERENCE PRESENTATIONS
From the University of Thessaly
- 1st International Meeting on Lung Cancer, October 23-24, 2020, Athens, Greece. B-PREIMMUNE (Blood derived preimmune platform) project, Xagara A., kosmatopoulos K., Baxevanis C., Makrithanasis, Vetsika EK., Markou A., Papadopoulos V., Georgoulias V., Kotsakis A.
- 4th Panhellenic Symeonide Cancer Research Conference, November 25 – November 2021, Thessaloniki, Greece. Immunological and Molecular Biomarkers in Peripheral Blood for the Selection of Cancer Patients for Immunotherapy (B-PREIMMUN project), Xagara A. and Kotsakis A.
- 1st Lung Cancer Conference, From RESEARCH to CLINICAL PRACTICE, Vouliagmeni, June 16-18, 2022, Immunological and Molecular Biomarkers in Peripheral Blood for the Selection of Lung Cancer Patients for Immunotherapy (B PREIMMUN project), Xagara Anastasia
- Masterclass on Immuno-oncology, Athens, Greece, 30 June-2 July , Cellular antitumor pre-existing immunity as prognostic and predictive biomarker for immunotherapy, Xagara Anastasia
- 1st Hippocrates Medical Conference of the University of Thessaly, Larissa, September 2-4, 2022, Preexisting Immunity as a Predictive Biomarker for the Selection of Patients with Non-Small Cell Lung Cancer for Immunotherapy, Xagara Anastasia, Gouleilmaki Maria, Fortis Sotirios, Georgoulias Vasilios, Baxevanis Konstantinos, Kotsakis Athanasios
- 3rd International Meeting on Lung Cancer, October 21-22, 2022, Athens, Greece. Combinatorial molecular and immunological biomarkers for immunotherapy response in NSCLC patients, Xagara Anastasia
- 8th Symposium on Advances in Cancer Immunology and Immunotherapy, 1-3 December, Athens, Greece. Selected short talk: Pre-existing cancer-antigen specific CD8+ T-cells as a biomarker for immunotherapy in NSCLC patients. Xagara A., Fortis S., Goulielmaki M., Koinis F., Chantzara E., Samaras G., Papadopoulos V., Georgoulias V., Baxevanis C.N., Kotsakis A.
- 5TH Symeonidio congress on Cancer Research, 1-3 December, Thessaloniki, Greece. Selected short talk: Immunological and Molecular blood derived biomarkers for Immunotherapy in NSCLC (B-PREIMMUN project). Xagara A., Fortis S., Goulielmaki M., Koinis F., Chantzara E., Samaras G., Papadopoulos V., Georgoulias V., Baxevanis C.N., Kotsakis A.
- ESMO Immuno-Oncology 2022 meeting, 6-9 December, Geneva, Switzerland. Best Poster Award. Poster presentation: Peripheral pre-existing T-cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients. Xagara A., Fortis S., Goulielmaki M., Koinis F., Chantzara E., Samaras G., Papadopoulos V., Georgoulias V., Baxevanis C.N., Kotsakis A.
- 29th HeSMO, 5-9 April, Athens, Greece. Poster presentation: Pre-existing immunity as a predictive biomarker for immunotherapy response in patients with Non-small cell lung cancer (NSCLC). Xagara A., Goulielmaki M., Fortis S., Koinis F., Chantzara E., Kokkalis A., Christodoulopoulos G., Samaras G., Papadopoulos V., Georgoulias V., Baxevanis C.N., Kotsakis A.
From KAAK
- CIMT Summer School, Verona-Illasi, Italy, 5-8 September 2022. Dynamics of TCR repertoire and immune-related genes in cancer. Goulielmaki M., Panagiota Batsaki P., Zoumpourlis V., Adamaki M., Baxevanis CN., Fortis SP.
- 21st International Conference on Progress in Vaccination Against Cancer (PIVAC-22), Torino, Italy, 26–28 September 2022. Immunotherapy-induced alterations in the TCR Vβ repertoire of non-small cell lung cancer patients. Goulielmaki M., Batsaki P., Gritzapis AD., Xagara A., Kotsakis A., Baxevanis CN., Fortis SP.
- 21st International Conference on Progress in Vaccination Against Cancer (PIVAC-22), Torino, Italy, 26–28 September 2022. Lecture title: Dynamics of TCR repertoire and immune-related genes in cancer. Dr. Sotirios P. Fortis
- Masterclass on Immuno-oncology, Athens, Greece, 30 June-2 July. Lecture title: T cells for adaptive antitumor responses. Dr. Maria Goulielmaki
- 7th Symposium on Advances in Cancer Immunology and Immunotherapy, Athens, Greece, 2-4, December 2021. Keynote lecture: Abscopal effect and TCR diversity in cancer inhibitors. Dr. Sotirios P. Fortis
- 5th Medical Congress of Psychosomatic Medicine, Nafplion, October 21-23. Talk title: Biomarkers of response to treatment of patients with lung cancer and psychoneurological extensions. Dr. Maria Goulielmaki
- 1st Lung Cancer Conference. From RESEARCH to CLINICAL PRACTICE. Vouliagmeni, June 16-18, 2022. Talk title: TCR repertoire changes after treatment in lung cancer. Dr. Maria Goulielmaki
